Resumo O estudo visa analisar a prevalência de estadiamento avançado ao diagnóstico do câncer do colo do útero e sua associação com indicadores individuais e contextuais socioeconômicos e de oferta de serviços de saúde no Brasil. Estudo transversal, realizado com casos de câncer do colo do útero em mulheres de 18 a 99 anos, no período de 2006 a 2015, extraídos do Integrador de Registros Hospitalares de Câncer. Variáveis contextuais foram coletadas no Atlas do Desenvolvimento Humano, no Cadastro Nacional de Estabelecimentos de Saúde e no Sistema de Informações Ambulatoriais. Usou-se o modelo de regressão de Poisson multinível com intercepto aleatório. A prevalência de diagnóstico em estádio avançado foi de 48,4%, apresentando associação com idades mais avançadas (RP 1,06; IC 1,01-1,10), raça/cor da pele preta, parda e indígena (RP 1,04; IC 1,01-1,07), menores níveis de escolaridade (RP 1,28; IC 1,16-1,40), ausência de parceiro conjugal (RP 1,10; IC 1,07-1,13), encaminhamento do tipo público ao serviço de saúde (RP 1,07; IC 1,03-1,11) e menor taxa de realização de exame citopatológico (RP 1,08; IC 1,01-1,14). Os resultados reforçam a necessidade de melhorias no programa nacional de prevenção do câncer do colo do útero em áreas com baixa cobertura da citologia oncótica. Brasil transversal 1 9 anos 200 2015 Câncer Humano Ambulatoriais Usouse Usou se aleatório 484 48 4 48,4% RP 1,06 106 06 1,011,10, 101110 1,01 1,10 , 01 10 1,01-1,10) raçacor raça cor preta 1,04 104 04 1,011,07, 101107 1,07 07 1,01-1,07) 1,28 128 28 1,161,40, 116140 1,16 1,40 16 40 1,16-1,40) 110 1,071,13, 107113 1,13 13 1,07-1,13) 107 1,031,11 103111 1,03 1,11 03 11 1,03-1,11 1,08 108 08 1,011,14. 101114 1,14 . 14 1,01-1,14) oncótica 20 201 48,4 1,0 0 011 1,011,10 10111 101 1,1 1,01-1,10 1,011,07 10110 1,01-1,07 1,2 12 2 161 1,161,40 11614 116 140 1,4 1,16-1,40 071 1,071,13 10711 113 1,07-1,13 031 1,031,1 10311 103 111 1,03-1,1 1,011,14 114 1,01-1,14 48, 1, 1,011,1 1011 1,01-1,1 1,011,0 1,01-1,0 1,161,4 1161 1,16-1,4 1,071,1 1071 1,07-1,1 1,031, 1031 1,03-1, 1,011, 1,01-1, 1,161, 1,16-1, 1,071, 1,07-1, 1,031 1,03-1 1,011 1,01-1 1,161 1,16-1 1,071 1,07-1 1,03- 1,01- 1,16- 1,07-

Abstract The scope of this study is to analyze the prevalence of advanced stage diagnosis of cervical cancer and its association with individual and contextual socioeconomic and healthcare service indicators in Brazil. A cross-sectional study was conducted using cervical cancer cases in women aged 18 to 99 years, from 2006 to 2015, extracted from the Hospital Cancer Registry (HCR) Integrator. Contextual variables were collected from the Atlas of Human Development in Brazil; the National Registry of Health Institutions (NRHI); and the Outpatient Information System. Multilevel Poisson Regression with random intercept was used. The prevalence of advanced stage diagnosis was 48.4%, revealing an association with older age groups (PR 1.06; CI 1.01-1.10), black, brown, and indigenous race/skin color (PR 1.04; CI 1.01-1.07), lower levels of schooling (PR 1.28; CI 1.16-1.40), no marital partner (PR 1.10; CI 1.07-1.13), public referral to the health service (PR 1.07; CI 1.03-1.11), and lower rates of cytological examination (PR 1.08; CI 1.01-1.14). The results reinforce the need for improvements in the national cervical cancer prevention program in areas with low coverage of oncotic cytology. Brazil crosssectional cross sectional 1 9 years 200 2015 HCR (HCR Integrator NRHI (NRHI) System used 484 48 4 48.4% PR 1.06 106 06 1.011.10, 101110 1.01 1.10 , 01 10 1.01-1.10) black brown raceskin race skin 1.04 104 04 1.011.07, 101107 1.07 07 1.01-1.07) 1.28 128 28 1.161.40, 116140 1.16 1.40 16 40 1.16-1.40) 110 1.071.13, 107113 1.13 13 1.07-1.13) 107 1.031.11, 103111 1.03 1.11 03 11 1.03-1.11) 1.08 108 08 1.011.14. 101114 1.14 . 14 1.01-1.14) cytology 20 201 (NRHI 48.4 1.0 0 011 1.011.10 10111 101 1.1 1.01-1.10 1.011.07 10110 1.01-1.07 1.2 12 2 161 1.161.40 11614 116 140 1.4 1.16-1.40 071 1.071.13 10711 113 1.07-1.13 031 1.031.11 10311 103 111 1.03-1.11 1.011.14 114 1.01-1.14 48. 1. 1.011.1 1011 1.01-1.1 1.011.0 1.01-1.0 1.161.4 1161 1.16-1.4 1.071.1 1071 1.07-1.1 1.031.1 1031 1.03-1.1 1.011. 1.01-1. 1.161. 1.16-1. 1.071. 1.07-1. 1.031. 1.03-1. 1.011 1.01-1 1.161 1.16-1 1.071 1.07-1 1.031 1.03-1 1.01- 1.16- 1.07- 1.03-

Abstract Multimorbidity, namely the presence of two or more chronic non-communicable diseases, is directly associated with behavioral factors. This study sought to estimate the prevalence of multimorbidity among young Brazilians by linking it to different social and lifestyle determinants. It involved a cross-sectional study of the data source, namely the 2019 National Health Survey. Data from individuals aged between 15 and 24 years (n = 10,460) were selected. Associated factors were investigated by calculating the Prevalence Ratio with robust variance, suitable for bivariate and multivariate analysis. The prevalence of multimorbidity in young people was estimated at 7.84% (95%CI: 7.01-8.75; N: 2,455,097). The most common conditions were mental illness, depression, asthma or bronchitis and chronic back problems. In the adjusted model, young females (PR: 1.84; 95%CI: 1.44-2.36), obese youths (PR: 1.97; 95%CI: 1.45-2.68) and former smokers (PR: 1.46; 95%CI: 1.12-1.90) showed a higher prevalence of multimorbidity. It was also revealed that the prevalence ratio for multimorbidity increased by 5% for each year of the individual’s life. This study identified an association of multimorbidity with social determinants and lifestyle.

Resumo A multimorbidade, presença de duas ou mais doenças crônicas não transmissíveis, está diretamente associada a fatores comportamentais. O objetivo da pesquisa foi estimar a prevalência de multimorbidade em jovens brasileiros relacionando-a aos diferentes determinantes sociais e de estilo de vida. Trata-se de um estudo transversal cuja fonte de dados foi a Pesquisa Nacional de Saúde em 2019. Foram selecionados dados de indivíduos com idade entre 15 e 24 anos (n = 10.460). Os fatores associados foram investigados por meio do cálculo da razão de prevalência com variância robusta, adequado para análise bivariada e multivariada. A prevalência de multimorbidade nos jovens foi estimada em 7,84% (IC95%: 7,01-8,75; N: 2.455.097). Os agravos mais comuns foram doenças mentais, depressão, asma ou bronquite e problemas crônicos de coluna. No modelo ajustado, jovens do sexo feminino (RP: 1,84; IC95%: 1,44-2,36), obesos (RP: 1,97; IC95%: 1,45-2,68) e ex-fumantes (RP: 1,46; IC95%: 1,12-1,90) apresentaram maiores prevalências para multimorbidade. A razão de prevalência para multimorbidade aumentou 5% a cada ano de vida do indivíduo. Este estudo identificou uma associação de multimorbidade com determinantes sociais e estilo de vida.

RESUMEN Objetivo Analizar las tendencias en la incidencia y mortalidad por cáncer de páncreas en los países latinoamericanos. Método Se realizó un estudio ecológico con datos de incidencia de la Agencia Internacional de Investigación sobre Cáncer y datos de mortalidad de la Organización Mundial de la Salud. Se analizó la tendencia de incidencia por regresión de Joinpoint, la variación del promedio anual y el intervalo de confianza del 95%. Resultados Hubo tendencias crecientes en la incidencia en Brasil en varones entre 40 y 59 años, y una reducción en Costa Rica. En las mujeres, hubo estabilidad en todos los grupos de edad. Las tasas de mortalidad aumentaron en los ancianos en Brasil (AAPC: 1,09%; IC 95%: 0,76; 1.42), Perú (AAPC: 1,76%; IC 95%: 0,36; 3,17) y El Salvador (AAPC: 2,88%; 95% IC 0,38; 5,43), mientras que en México hubo una reducción. En las mujeres, esta tasa aumentó en Brasil (AAPC: 1,38%; IC 95%: 1,07; 1.69), Perú (AAPC: 2,25%; IC 95%: 0,68; 3.85), Chile (AAPC: 3,62%; IC 95%: 1,96; 5,31), Nicaragua (AAPC: 2,51%; IC 95%: 0,36; 4,71) y Paraguay (AAPC: 1,17%; IC 95%: 0,37; 1,98) y se observó una tendencia a la baja en Colombia y Ecuador. Conclusiones El cáncer de páncreas tuvo una mayor incidencia en la población anciana de ambos sexos; cabe también señalar que debido a este aumentó su mortalidad en las mujeres.

ABSTRACT Objectives To analyze trends in pancreatic cancer incidence and mortality in Latin American countries. Methods An ecological study with incidence data from the International Agency for Research on Cancer and mortality data from the World Health Organization. The trend of incidence by Joinpoint regression, the variation of the annual average and the 95% confidence interval were analyzed. Results There were increasing trends in incidence in Brazil, in males, aged 40-59 years, and reduction in Costa Rica. In females, there was stability in all age groups. The mortality rates increased in the elderly in Brazil (AAPC: 1.09%; 95% CI: 0.76; 1.42), Peru (AAPC: 1.76%; 95% CI: 0.36; 3.17) and El Salvador (AAPC: 2.88%; 95% CI: 0.38; 5.43), while in Mexico, there was a reduction. In females, this rate increased in Brazil (AAPC: 1.38%; 95% CI: 1.07; 1.69), Peru (AAPC: 2.25%; 95% CI: 0.68; 3.85), Chile (AAPC: 3.62%; 95% CI: 1.96; 5.31), Nicaragua (AAPC: 2.51%; 95% CI: 0.36; 4.71) and Paraguay (AAPC: 1.17%; 95% CI: 0.37; 1.98) and a downward trend was observed in Colombia and Ecuador. Conclusions Pancreatic cancer had a higher incidence in the elderly population of both sexes and an increase of the mortality trend in females was noted.

Objective: To analyze the trend in the incidence rates of major salivary gland cancer in population-based cancer registries in Spain. Methods: The following Spanish cancer registries with a minimum follow-up period of 10 years were selected: Albacete, Asturias, Granada, Murcia, Navarre, Tarragona and Zaragoza. Adjusted incidence rates were calculated. Joinpoint software was utilized to calculate change estimations in incidence rates for the period 1991-2001. Results: Joinpoint analysis revealed a statistically significant decreasing trend with an annual percent change of -5.3% (95% CI: -8.7 to -1.8). Conclusion: The incidence of major salivary gland cancers in Spain was low and a decreasing trend was identified between 1991 and 2001.

Objetivo: Analizar la evolución de las tasas de incidencia de los cánceres de glándulas salivales mayores en los Registros de Cáncer de Base Poblacional españoles. Métodos: Se seleccionaron los registros con un mínimo de 10 años de seguimiento: Albacete, Asturias, Granada, Murcia, Navarra, Tarragona y Zaragoza. Se calcularon las tasas de incidencia ajustadas a la población española a mitad del periodo. La tendencia de las tasas ajustadas se analizó con el programa joinpoint para 1991-2001. Resultados: El análisis joinpoint reveló una tendencia de reducción estadísticamente significativa, con un porcentaje anual de cambio del -5,3% (intervalo de confianza del 95%: -8,7 a -1,8). Conclusión: La incidencia de los cánceres de glándulas salivales mayores en España ha sido baja y se ha identificado una tendencia a la reducción entre 1991 y 2001.